A Phase II Study of Lenalidomide in Combination With Gemcitabine in Subjects With Untreated Advanced Carcinoma of the Pancreas.
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2013
At a glance
- Drugs Gemcitabine (Primary) ; Lenalidomide (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 01 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 May 2011 Planned End Date changed from 1 Apr 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.
- 01 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.